Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Biol Psychiatry. 2007 Feb 15;61(4):551-3. Epub 2006 Aug 22.

Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study.

Author information

  • 1Department of Child and Adolescent Neuropsychiatry, Medical University of Vienna, Vienna, Austria. paul.amminger@meduniwien.ac.at

Abstract

BACKGROUND:

There is increasing evidence that fatty acid deficiencies or imbalances may contribute to childhood neurodevelopmental disorders.

METHODS:

We conducted a randomized, double-blind, placebo-controlled 6-week pilot trial investigating the effects of 1.5 g/d of omega-3 fatty acids (.84 g/d eicosapentaenoic acid, .7 g/d docosahexaenoic acid) supplementation in 13 children (aged 5 to 17 years) with autistic disorders accompanied by severe tantrums, aggression, or self-injurious behavior. The outcome measure was the Aberrant Behavior Checklist (ABC) at 6 weeks.

RESULTS:

We observed an advantage of omega-3 fatty acids compared with placebo for hyperactivity and stereotypy, each with a large effect size. Repeated-measures ANOVA indicated a trend toward superiority of omega-3 fatty acids over placebo for hyperactivity. No clinically relevant adverse effects were elicited in either group.

CONCLUSIONS:

The results of this study provide preliminary evidence that omega-3 fatty acids may be an effective treatment for children with autism.

Comment in

PMID:
16920077
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk